Act Now: Jovine's Latest Biotech Pick Revealed - May 05

Immunogen was taken over 33 days after he said it would for a 463% gain... [Logotype]( When Dylan Jovine releases a new biotech, it pays to act fast. Immunogen was taken over 33 days after he said it would for a 463% gain... We just sold Viking Therapeutics for a 273% gain... He sold Chemocentryx for a 300% gain... And, today I have some great news: He just released his [#1 Biotech for April.]( I urge you to get the details on his latest pick before it's too late. You'll discover: 1. How a $4 micro-cap beat the odds to win an FDA approval on a new kind of "Smart Chemo" that's like a heat-seeking missile against cancer. 2. Why the Journal Nature is calling it, "The Dawn of a New Era Against Cancer." 3. Why Big Pharma giants Pfizer, AbbVie, Merck and Johnson & Johnson put $60 billion into this treatment within the past 12 months. [Get the name of the stock here ]( Never before has so much money invested in a new cancer treatment so quickly. Morgan Stanley estimates the market is worth at least $140 billion. But right now, its stock price is just a tiny fraction of that size. [See why this $4 "Smart Chemo" stock can soar 300% (or more) ]( All the best, Simmy Adelman, Publisher Behind the Markets We are often approached by other businesses with special оffеrs for our readers. While many don’t make the cut, the message above is one we believe deserves your consideration. Email sent by Finance and Investing Traffic, LLC, owner and operator of Own Inner Voice (OIV). This offer is brought to you by Own Inner Voice. 221 W 9th St # Wilmington, DE 19801. If you would like to unsubscribe from receiving offers brought to you by Own Inner Voice [click here](. To ensure you keep receiving our emails, be sure to [whitelist us](. Need assistance? Our dedicated support team is just a click away! [Connect with us](mailto:support@owninnervoice.com) for a seamless experience. Own Inner Voice. © Аll Rіghts Reserved 2024 [Privacy Policy]( | [Terms & Conditions]( [Unsubscribe]( [Logotype] [Unsubscribe](